Stellixir Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.95 M
as on 16-12-2024
- Revenue 155.60%
(FY 2022)
- Profit 291.29%
(FY 2022)
- Ebitda 624.73%
(FY 2022)
- Net Worth 98.00%
(FY 2022)
- Total Assets 19.67%
(FY 2022)
About Stellixir Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.95 M.
Beedarekere Ramegowda and Papayya Janardhana serve as directors at the Company.
- CIN/LLPIN
U74900KA2014PTC076297
- Company No.
076297
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Stellixir Biotech Private Limited offer?
Stellixir Biotech Private Limited offers a wide range of products and services, including Architectural & Civil Engineering, Architectural Services.
Who are the key members and board of directors at Stellixir Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Beedarekere Ramegowda  | Director | 10-Sep-2014 | Current |
| Papayya Janardhana | Director | 10-Sep-2014 | Current |
Financial Performance of Stellixir Biotech.
Stellixir Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 155.6% increase. The company also saw a substantial improvement in profitability, with a 291.29% increase in profit. The company's net worth Soared by an impressive increase of 98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stellixir Biotech?
Unlock access to Stellixir Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Feb 2015 | ₹0.95 M | Open |
How Many Employees Work at Stellixir Biotech?
Unlock and access historical data on people associated with Stellixir Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stellixir Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stellixir Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
